22-January-2013
Introducing a certified solution standard of the new anticonvulsant drug Retigabine.
|
Retigabine, 1.0 mg/mL
|
R-018
|
1.0 mg/mL in Acetonitrile
Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga® in the US and Trobalt® in the EU. This certified solution standard is suitable for use as starting material in calibrators and controls for LC/MS or GC/MS methods in clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring, or pharmaceutical research applications.
|
|
|
Cerilliant will soon introduce certified solution standards of the internal standard Retigabine-D4 and N-Acetylretigabine, a major urinary metabolite of retigabine.
Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.
|